Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Humanigen Granted U.S. Patent Titled 'METHOD OF INCREASING THE EFFICACY OF CAR-T IMMUNOTHERAPY USING LENZILUMAB'

Author: Benzinga Newsdesk | June 13, 2023 04:05pm

chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11673962

Posted In: HGEN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist